Note 11 - Stock-based Compensation

3 Months Ended

Sep. 30, 2022

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

(11) Stock-Based Compensation

Stock Option Activity Summary

The Company’s stock option activity for the three months ended September 30, 2022 is as follows:

	Shares			Weighted Average
	(In thousands)			Exercise Price
Outstanding at June 30, 2022	$	1,029		$	1.35
Granted		155			0.44
Exercised		—			—
Canceled or expired		(72	)		5.81
Outstanding at September 30, 2022	$	1,112		$	0.93

The aggregate intrinsic value of options exercisable at September 30, 2022 was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $495 thousand related to stock options will be recognized over a weighted-average period of 2.58 years.

The table below details the Company’s stock options outstanding as of September 30, 2022:

			Options
			Outstanding						Options
			Weighted-						Exercisable
			Average		Weighted-				Weighted-
	Number		Remaining		Average		Number		Average
	Outstanding (In		Contractual		Exercise		Exercisable (In		Exercise
Range of exercise prices	thousands)		Life (Years)		Price		thousands)		Price
$0.44 - 0.64		1,031		9.60	$	0.61		—	$	—
$1.85 - 2.83		13		5.99		2.15		10		2.08
$5.30 - 5.85		68		4.61		5.63		68		5.63
$0.44- 5.85		1,112		9.25	$	0.93		77	$	5.18

Compensation costs recognized related to stock option awards were $46 thousand and $0 for each of the three months ended September 30, 2022, and 2021.

Restricted Stock

The Company’s restricted stock activity for the three months ended September 30, 2022, is as follows:

				Weighted
				Average
	Shares			Grant-Date
	(In thousands)			Fair Value
Outstanding at June 30, 2022	$	2,276		$	1.30
Granted		—			—
Vested		—			—
Canceled or expired		(2	)		2.02
Outstanding at September 30, 2022	$	2,274		$	1.30

Stock compensation expenses related to restricted stock were $341 thousand and $359 thousand for the three months ended September 30, 2022, and 2021, respectively. The remaining stock-based compensation expense of $2.3 million related to restricted stock awards granted will be recognized over a weighted-average period of 2.31 years.